Meet a Company Series : MSD - Core interests & collaboration opportunities
12.05.2026 17:00 – 19:00
The School of Pharmaceutical Sciences of the University of Geneva and Unitec, its technology transfer office, invite you to a new session of the Meet a Company welcoming:
MSD - Core interests & collaboration opportunities
With the kind participation of:
> John Copeland, Head of International Business Development & Transactions, MSD
> Laura Dickens, Associate Director, Discovery Transactions, MSD
Join us at this event to learn more about MSD history of successful partnerships, key areas of interest for collaboration, as well as how to connect and engage with the team.
MSD is a global biopharmaceutical company focused on identifying cutting-edge science, regardless of therapeutic area or modality, and collaborating together to make the most significant difference for patients. Their key areas of interest include cardiometabolic and respiratory diseases, immunology, infectious diseases & vaccines, neuroscience, oncology, ophthalmology and enabling technologies.
The presentation of 45min will be followed by a Q&A session and a networking aperitif. The event will be in English.
This event is free but registration is mandatory.
Lieu
Bâtiment: CMU
Auditoire Reverdin (CMU - B02.2526)
Organisé par
UnitecIntervenant-e-s
John Copeland, Head of International Business Development & Transactions, MSDLaura Dickens, Associate Director, Discovery Transactions, MSD
Pr Yogeshvar Kalia, Professor, School of Pharmaceutical Sciences, Faculté des Sciences, UNIGE
Dre Jennifer Cadby, Associée aux transferts de technologies, Unitec, UNIGE
entrée libre
Inscription
Date limite d'inscription: 12.05.2026

haut